August 17, 2023 02:51 PM EDTUpdated 03:07 PM
Pharma

Doc­tors With­out Bor­ders re­jects Vi­iV Health­care's pro­posed con­tract for long-act­ing HIV PrEP drug

Paul Schloesser

Associate Editor

Med­ical ad­vo­ca­cy group Médecins Sans Fron­tières (MSF), al­so known as Doc­tors With­out Bor­ders, called up­on Vi­iV Health­care Thurs­day to cut a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times